source Post navigation Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes – The New England Journal of Medicine Controlled induction of type 2 diabetes in mice using high fat diet and osmotic-mini pump infused streptozotocin – Nature